Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Oncogene ; 39(21): 4241-4256, 2020 05.
Article in English | MEDLINE | ID: mdl-32286519

ABSTRACT

T-cell protein tyrosine phosphatase (TC-PTP), encoded by Ptpn2, has been shown to function as a tumor suppressor during skin carcinogenesis. In the current study, we generated a novel epidermal-specific TC-PTP-overexpressing (K5HA.Ptpn2) mouse model to show that TC-PTP contributes to the attenuation of chemically induced skin carcinogenesis through the synergistic regulation of STAT1, STAT3, STAT5, and PI3K/AKT signaling. We found overexpression of TC-PTP increased epidermal sensitivity to DMBA-induced apoptosis and it decreased TPA-mediated hyperproliferation, coinciding with reduced epidermal thickness. Inhibition of STAT1, STAT3, STAT5, or AKT reversed the effects of TC-PTP overexpression on epidermal survival and proliferation. Mice overexpressing TC-PTP in the epidermis developed significantly reduced numbers of tumors during skin carcinogenesis and presented a prolonged latency of tumor initiation. Examination of human papillomas and squamous cell carcinomas (SCCs) revealed that TC-PTP expression was significantly reduced and TC-PTP expression was inversely correlated with the increased grade of SCCs. Our findings demonstrate that TC-PTP is a potential therapeutic target for the prevention of human skin cancer given that it is a major negative regulator of oncogenic signaling.


Subject(s)
Carcinoma, Squamous Cell/enzymology , Epidermis/metabolism , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Neoplastic , Neoplasm Proteins/metabolism , Papilloma/enzymology , Protein Tyrosine Phosphatase, Non-Receptor Type 2/biosynthesis , Signal Transduction , Skin Neoplasms/enzymology , Animals , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/pathology , Cell Proliferation , Cell Survival , Epidermis/pathology , Humans , Mice , Mice, Transgenic , Neoplasm Proteins/genetics , Papilloma/genetics , Papilloma/pathology , Protein Tyrosine Phosphatase, Non-Receptor Type 2/genetics , Skin Neoplasms/genetics , Skin Neoplasms/pathology
2.
Mol Carcinog ; 58(9): 1640-1647, 2019 09.
Article in English | MEDLINE | ID: mdl-31264291

ABSTRACT

T-cell protein tyrosine phosphatase (TC-PTP, encoded by PTPN2) is a nonreceptor PTP that is most highly expressed in hematopoietic tissues. TC-PTP modulates a variety of physiological functions including cell cycle progression, cell survival and proliferation, and hematopoiesis through tyrosine dephosphorylation of its target substrates, such as EGFR, JAK1, JAK3, STAT1, and STAT3. Studies with whole or tissue-specific loss of TC-PTP function transgenic mice have shown that TC-PTP has crucial roles in the regulation of the immune response, insulin signaling, and oncogenic signaling. More recently, the generation of epidermal-specific TC-PTP-deficient mice for use in multistage skin carcinogenesis bioassays demonstrated that TC-PTP suppresses skin tumor formation by negatively regulating STAT3 and AKT signaling. Further investigation showed that TC-PTP also minimizes UVB-induced epidermal cell damage by promoting apoptosis through the negative regulation of Flk-1/JNK signaling. These findings provide major evidence for a tumor suppressive function for TC-PTP against environment-induced skin cancer. Here, we will discuss TC-PTP, its substrates, and its functions with an emphasis on its role in skin carcinogenesis.


Subject(s)
Carcinogenesis/metabolism , Epithelial Cells/metabolism , Protein Tyrosine Phosphatase, Non-Receptor Type 2/metabolism , Animals , Cell Cycle/physiology , Cell Proliferation/physiology , Cell Survival/physiology , Epidermis/metabolism , Epidermis/physiology , Epithelial Cells/physiology , Hematopoiesis/physiology , Humans , Signal Transduction/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...